Inventor · disambiguated record
Kevin Duane Bunker
Also filed as: BUNKER KEVIN DUANE
42 granted patents·47 pending applications·78 citations·filing 2014–2025
97Inventor score
Files withRECURIUM IP HOLDINGS LLC61KALYRA PHARMACEUTICALS INC10ZENO MAN INC6ZENO ROYALTIES & MILESTONES LLC6IMMUNOME INC5
Top patents by PatentIndex Score
89 records- 0196US11813260B1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Granted Nov 14, 2023·1 cites·20 claims
- 0295US11339162B1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0393US11813259B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Nov 14, 2023·1 cites·17 claims
- 0493US9693975B2Bicyclic analgesic compoundsKALYRA PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·12 cites·13 claims
- 0593US9447025B2Bicyclic analgesic compoundsKALYRA PHARMACEUTICALS INC·Filed 2014·Granted Sep 20, 2016·15 cites·8 claims
- 0691US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0790US12186403B2Immunoconjugates and methodsIMMUNOME INC·Filed 2023·Granted Jan 7, 2025·1 cites·30 claims
- 0889US11806405B1Immunoconjugates and methodsZENO MAN INC·Filed 2022·Granted Nov 7, 2023·6 cites·42 claims
- 0989US9724316B2Bicyclic analgesic compoundsKALYRA PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·6 cites·22 claims
- 1089US9447026B2Bicyclic analgesic compoundsKALYRA PHARMACEUTICALS INC·Filed 2014·Granted Sep 20, 2016·9 cites·74 claims
- 1189US2024180899A1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 1287US12280121B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 22, 2025·0 cites·12 claims
- 1387US12274754B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 15, 2025·0 cites·12 claims
- 1487US11590126B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Feb 28, 2023·1 cites·97 claims
- 1587US11344546B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 31, 2022·1 cites·109 claims
- 1686US12285492B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 29, 2025·0 cites·13 claims
- 1786US12268750B2Immunoconjugates and methodsIMMUNOME INC·Filed 2024·Granted Apr 8, 2025·0 cites·3 claims
- 1883US11065234B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·1 cites·32 claims
- 1982US11098030B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Aug 24, 2021·1 cites·13 claims
- 2082US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 2182US10251851B2Bicyclic analgesic compoundsKALYRA PHARMACEUTICALS INC·Filed 2017·Granted Apr 9, 2019·2 cites·24 claims
- 2281US11278532B2Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 22, 2022·1 cites·22 claims
- 2381US10189780B2Bicyclic alkyl compounds and synthesisKALYRA PHARMACEUTICALS INC·Filed 2014·Granted Jan 29, 2019·2 cites·11 claims
- 2480US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 2579US11124518B2L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Sep 21, 2021·2 cites·22 claims
- 2677US10513509B2EGFR inhibitor compoundsKALYRA PHARMACEUTICALS INC·Filed 2017·Granted Dec 24, 2019·1 cites·24 claims
- 2776US10793504B2Methods for cross couplingRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Oct 6, 2020·1 cites·22 claims
- 2875US10308609B2Bicyclic compoundsKALYRA PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·2 cites·22 claims
- 2974US11318134B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 3, 2022·0 cites·82 claims
- 3073US12049460B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted Jul 30, 2024·0 cites·20 claims
- 3173US2021330651A1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3272US10959989B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 30, 2021·0 cites·3 claims
- 3371US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 3471US10493060B2Spirocyclic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Granted Dec 3, 2019·1 cites·11 claims
- 3570US11999728B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 3670US11065233B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·0 cites·24 claims
- 3769USRE50643EBenzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Oct 21, 2025·0 cites·100 claims
- 3869US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3968US9951026B2Heterocyclic vinyl autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Apr 24, 2018·1 cites·19 claims
- 4066US12410204B2Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Sep 9, 2025·0 cites·19 claims
- 4166US11724971B2Process for making [1.1.1]propellaneRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Aug 15, 2023·0 cites·21 claims
- 4266US2024261295A1Combinations of wee1 inhibitors and anti-cd47 antibodiesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4364US2024299395A1Combination therapies comprising wee1 inhibitors and dna damage response (ddr) inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4464US2024325397A1Use of combination therapy for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4563US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 4663US2024325412A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4763US2024335447A1Wee1 inhibitor for cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 4862US2021317124A11,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4962US2021115058A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 5061US2019298668A1Bicyclic analgesic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kevin Duane Bunker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →